19 Jan 2017
2016 — A year of data integrity issues and pharma non-compliances
Data integrity was a hot topic of discussion in the pharmaceutical industry throughout 2016. Largely, it was a year when non-compliances made headlines — regulators were turned away by drug companies, contract research organ...
12 Jan 2017
Trump’s comments on drug prices sink pharma stocks; Teva lowers guidance by $ 1 billion
The New Year began with the JP Morgan Healthcare Conference— the drug industry’s annual investor meet — where industry leaders were busy announcing deals, until Donald Trump accused the industry of “ge...
05 Jan 2017
Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend
In less than three weeks, Donald Trump will assume office as the President of the United States. He has mentioned that he wants Medicare (a national social insurance program) to directly negotiate the price it pays for prescriptio...